Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.
Michael Markus BonelliHelga RadnerAndreas KerschbaumerDaniel MrakMartina DurechovaJutta StiegerRusmir HusicPeter MandlJosef S SmolenChristian DejacoDaniel AletahaPublished in: Annals of the rheumatic diseases (2022)
NCT03263715.